spacer
home > > autumn 2003 > recruiting hiv infected patients for anti-retroviral clinical trials in cee and the russian federation
PUBLICATIONS


Recruiting HIV Infected Patients for Anti-Retroviral Clinical Trials in CEE and the Russian Federation

Over the past decade the number of international clinical trials performed in Central and Eastern Europe (CEE) has continuously increased. Amongst these countries, Poland has become a regular partner in the conduct of clinical trials although this is not yet the case for most other CEE countries. Since the start of the first trial in the Russian Federation only about 120 trials have been conducted there (1). However, given the positive aspects of performing clinical trials in CEE countries and the Russian Federation, one can expect the number of trials to increase over time. To explain, site staff tend to be very motivated and eager to participate in clinical trials, while the quality of work and ICH GCP compliance is largely impeccable. Even more important when conducting clinical trials, recruitment in CEE countries and the Russian Federation appears to be higher than in most Western European countries. This again is not only because of the motivated staff but also because of the availability of the potential trial population.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Stefan Comhaire, Project Manager at Medisearch International

Having begun his career in basic scientific research, Stefan Comhaire joined Medisearch International over five years ago. Starting in clinical research as a CRA, he is now a Project Manager in charge of setting up the collaboration with the CEE and the Russian Federation five years ago, during which he established long-lasting collaboration with Russian and Polish investigators. As a specialist in infectious diseases, he has led several clinical trials in HIV, most of them also recruiting in Eastern Europe and/or Russia.

spacer
Stefan Comhaire
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Optimizing pharmaceutical processes

An increase in requirements from regulatory agencies around the world, combined with a growing demand for drugs in prefilled injections systems a trend that industry experts have projected will continue has led pharmaceutical and biotech supply chains to gain in significance. Well established and optimized processes are crucial for offering uninterrupted market supply. To satisfy its customers a CDMO must foster flexibility, efficiency and safety throughout the entire supply chain. The most important goal for all parties involved in the bio-pharma business is maximization of product quality where even small decisions can make a big difference. Future-oriented pharma processes can add value to any compound.
More info >>

White Papers

Clinical Trial-Specific Travel Programs as a Patient Retention Tool

For many patients, participating in a clinical trial is a major endeavor. Depending on the protocol requirements, study visits can be exhausting. There are a number of reasons why a patient may choose to participate in a trial only to drop out. Conversely, there are several approaches to proactively try to prevent this from happening. There are various methods professionals implement for patient retention. This white paper explores patient travel services as one patient retention strategy.
More info >>

 
Industry Events

CPhI Festival of Pharma

5-16 October 2020, Virtual

A virtual gathering for the pharmaceutical industry, the CPhI Festival of Pharma has been created to fill the gap left by in-person events at a time when travel and gatherings are off the cards.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement